When we do things like quantum calculations, we look at the confirmer space. So what that does is give us insight into how a ...

(NASDAQ: DXCM), the global leader in glucose biosensing, announced today the FDA has cleared Dexcom Smart Basal, the first and only CGM-integrated basal insulin dosing optimizer designed for adults ...

NICE has issued draft guidance recommending broader use of tranexamic acid across surgical settings to reduce bleeding, ...

“Sleep doctors will use it to help someone adjust the timing of their sleep,” Dr. Winter says. The exact timing of taking ...

KKCTH educates families on carb counting for better insulin management in children with type-1 diabetes during World Diabetes Day events.

New artificial intelligence technology is helping diagnose the U.S.’s most deadly cancer sooner, greatly improving the ...

Mitochondrial DNA (mtDNA) exhibits a degree of resistance to mutagenesis under genotoxic stress, and this study on the mitochondrial Transcription Factor A (TFAM) presents valuable data concerning the ...

Dexcom (NSDQ:DXCM) announced today that the FDA cleared its Smart Basal CGM-integrated basal insulin dosing optimizer.

Neil Hannay reports on the investigation and resolution of calibration limitations experienced during flowmeter development ...

The World’s Largest Egg belongs to this cherished tradition alongside such legendary attractions as the Corn Palace in Mitchell, South Dakota, the Blue Whale of Catoosa in Oklahoma, and the countless ...

Investing.com -- GT Biopharma Inc (NASDAQ:GTBP) stock gained 4.1% on Wednesday as the company progresses its Phase 1 clinical trial for lead cancer therapy GTB 3650 to higher dosing levels.